ACORDA THERAPEUTICS, INC. 
By NEW YORK, January 10, 2014 /PRNewswire/ --
Today, Analysts' Corner announced new research reports highlighting Mettler-Toledo International Inc. (NYSE: MTD), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), DexCom, Inc. (NASDAQ: DXCM), The Spectranetics Corporation (NASDAQ: SPNC), and Acorda Therapeutics, Inc. (NASDAQ: ACOR). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Mettler-Toledo International Inc. Research Report
On January 7, 2014, Mettler-Toledo International Inc. (Mettler-Toledo) announced that it will participate at the Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 14, 2014 at 3:30 p.m. PT / 6:30 p.m. ET. The Company informed that a live webcast of the presentation will be available on the Investor Relations page of Mettler-Toledo's website. The Full Research Report on Mettler-Toledo International Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.analystscorner.com/r/full_research_report/ac69_MTD
--
BioMarin Pharmaceutical Inc. Research Report
On January 7, 2014, BioMarin Pharmaceutical Inc. (BioMarin) announced that its CEO, Jean-Jacques Bienaime is scheduled to present a company update at the 32nd Annual J.P. Morgan Healthcare Conference on January 13, 2014 at 10:30 a.m. PT. According to the Company, interested parties may access a live audio webcast of the conference call via the Investors section of the BioMarin's website. The Full Research Report on BioMarin Pharmaceutical Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.analystscorner.com/r/full_research_report/9b6c_BMRN
--
DexCom, Inc. Research Report
On January 7, 2014, DexCom, Inc. (DexCom) announced that it will participate at the J.P. Morgan 2014 Healthcare Conference at the Westin St. Francis Hotel in San Francisco. According to the Company, CEO of DexCom, Terry Gregg is scheduled to make the presentation on January 14, 2014 at 3:30 p.m. PST. The Full Research Report on DexCom, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.analystscorner.com/r/full_research_report/d377_DXCM
--
The Spectranetics Corporation Research Report
On January 6, 2014, The Spectranetics Corporation (Spectranetics) announced that its management team will represent the Company at the J.P. Morgan 32nd Annual Healthcare Conference on January 15, 2014 in San Francisco. According to the Company, Spectranetics' management is scheduled to present on the aforesaid date at 5:30 p.m. ET. Spectranetics informed that interested parties can access the live audio webcast of the presentation at the Company's website. The Full Research Report on The Spectranetics Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.analystscorner.com/r/full_research_report/82e6_SPNC
--
Acorda Therapeutics, Inc. Research Report
On January 7, 2014, Acorda Therapeutics, Inc. (Acorda) announced its participation at upcoming the J.P. Morgan Healthcare Conference, to be held at the Westin St. Francis Hotel in San Francisco, California. According to the Company, Ron Cohen, M.D., President and CEO of Acorda, is scheduled to present on January 13, 2014 at 11:00 a.m. PT. According to the Acorda, a live audio webcast of the presentation can be accessed under "Investor Events" in the Investor section of the Company's website. The Full Research Report on Acorda Therapeutics, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.analystscorner.com/r/full_research_report/d67c_ACOR
----
EDITOR NOTES:
1) This is not company news. We are an independent source and our views do
not reflect the companies mentioned.
2) Information in this release is fact checked and produced on a best efforts
basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human
and are prone to make mistakes. If you notice any errors or omissions, please notify
us below.
3) This information is submitted as a net-positive to companies mentioned, to
increase awareness for mentioned companies to our subscriber base and the investing
public.
4) If you wish to have your company covered in more detail by our team, or wish
to learn more about our services, please contact us at
pubco@EquityNewsNetwork.com.
5) For any urgent concerns or inquiries, please contact us at
compliance@EquityNewsNetwork.com.
6) Are you a public company? Would you like to see similar coverage on your
company? Send us a full investors' package to research@EquityNewsNetwork.com for
consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.
SOURCE Analysts' Corner
